Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Xilio Therapeutics (XLO) Return on Sales (2024 - 2025)

Historic Return on Sales for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to 0.1%.

  • Xilio Therapeutics' Return on Sales rose 64200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year change of. This contributed to the annual value of 9.55% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Xilio Therapeutics' Return on Sales is 0.1%, which was up 64200.0% from 1.78% recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Return on Sales ranged from a high of 0.1% in Q3 2025 and a low of 7.91% during Q4 2024